![](https://webarchive.library.unt.edu/eot2008/20090118123536im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 9: September 2007
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ![PDF](https://webarchive.library.unt.edu/eot2008/20090118123536im_/http://www.fda.gov/cder/graphics/pdf.gif)
ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
TABLET; ORAL
>D> WYGESIC
>D> AA + LEITNER PHARMS 650MG;65MG N84999 001 Se DISC
>A> @ 650MG;65MG N84999 001 Se DISC
ALBUTEROL
AEROSOL, METERED; INHALATION
>D> PROVENTIL
>D> BN + SCHERING 0.09MG/INH N17559 001 Se DISC
>A> @ 0.09MG/INH N17559 001 Se DISC
ALBUTEROL SULFATE
SOLUTION; INHALATION
ACCUNEB
>D> + DEY EQ 0.021% BASE N20949 002 Apr 30, 2001 Se CFTG
>A> AN + EQ 0.021% BASE N20949 002 Apr 30, 2001 Se CFTG
>A> ALBUTEROL SULFATE
>A> AN WATSON LABS EQ 0.021% BASE N77772 001 Sep 25, 2007 Se NEWA
>A> AN EQ 0.042% BASE N77772 002 Sep 25, 2007 Se NEWA
AMLODIPINE BESYLATE
>A> TABLET, ORALLY DISINTEGRATING; ORAL
>A> AMLODIPINE BESYLATE
>A> SYNTHON PHARMS EQ 2.5MG BASE N22026 001 Sep 27, 2007 Se NEWA
>A> EQ 5MG BASE N22026 002 Sep 27, 2007 Se NEWA
>A> + EQ 10MG BASE N22026 003 Sep 27, 2007 Se NEWA
TABLET; ORAL
AMLODIPINE BESYLATE
>A> AB WATSON LABS EQ 2.5MG BASE N77073 001 Sep 26, 2007 Se NEWA
>A> AB EQ 5MG BASE N77073 002 Sep 26, 2007 Se NEWA
>A> AB EQ 10MG BASE N77073 003 Sep 26, 2007 Se NEWA
>A> AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
>A> TABLET; ORAL
>A> AZOR
>A> DAIICHI SANKYO EQ 5MG BASE;20MG N22100 001 Sep 26, 2007 Se NEWA
>A> EQ 5MG BASE;40MG N22100 002 Sep 26, 2007 Se NEWA
>A> EQ 10MG BASE;20MG N22100 003 Sep 26, 2007 Se NEWA
>A> + EQ 10MG BASE;40MG N22100 004 Sep 26, 2007 Se NEWA
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE;
TABLET; ORAL
ADDERALL 10
>A> AB DURAMED RES 2.5MG;2.5MG;2.5MG;2.5MG N11522 007 Feb 13, 1996 Se CAHN
>D> AB SHIRE 2.5MG;2.5MG;2.5MG;2.5MG N11522 007 Feb 13, 1996 Se CAHN
ADDERALL 12.5
>A> AB DURAMED RES 3.125MG;3.125MG;3.125MG;3.125MG N11522 012 Aug 31, 2000 Se CAHN
>D> AB SHIRE 3.125MG;3.125MG;3.125MG;3.125MG N11522 012 Aug 31, 2000 Se CAHN
ADDERALL 15
>A> AB DURAMED RES 3.75MG;3.75MG;3.75MG;3.75MG N11522 013 Aug 31, 2000 Se CAHN
>D> AB SHIRE 3.75MG;3.75MG;3.75MG;3.75MG N11522 013 Aug 31, 2000 Se CAHN
ADDERALL 20
>A> AB DURAMED RES 5MG;5MG;5MG;5MG N11522 008 Feb 13, 1996 Se CAHN
>D> AB SHIRE 5MG;5MG;5MG;5MG N11522 008 Feb 13, 1996 Se CAHN
ADDERALL 30
>A> AB + DURAMED RES 7.5MG;7.5MG;7.5MG;7.5MG N11522 010 May 12, 1997 Se CAHN
>D> AB + SHIRE 7.5MG;7.5MG;7.5MG;7.5MG N11522 010 May 12, 1997 Se CAHN
ADDERALL 5
>A> AB DURAMED RES 1.25MG;1.25MG;1.25MG;1.25MG N11522 009 May 12, 1997 Se CAHN
>D> AB SHIRE 1.25MG;1.25MG;1.25MG;1.25MG N11522 009 May 12, 1997 Se CAHN
ADDERALL 7.5
>A> AB DURAMED RES 1.875MG;1.875MG;1.875MG;1.875MG N11522 011 Aug 31, 2000 Se CAHN
>D> AB SHIRE 1.875MG;1.875MG;1.875MG;1.875MG N11522 011 Aug 31, 2000 Se CAHN
ANAGRELIDE HYDROCHLORIDE
CAPSULE; ORAL
AGRYLIN
>D> AB + SHIRE EQ 1MG BASE N20333 002 Mar 14, 1997 Se DISC
>A> @ EQ 1MG BASE N20333 002 Mar 14, 1997 Se DISC
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM
TABLET, DELAYED RELEASE, FOR SOLUTION; ORAL
HALFLYTELY
>A> + BRAINTREE 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2. N21551 002 Sep 24, 2007 Se NEWA
CALCIPOTRIENE
>D> OINTMENT; TOPICAL
>D> DOVONEX
>D> + LEO PHARM 0.005% N20273 001 Dec 29, 1993 Se DISC
>A> @ 0.005% N20273 001 Dec 29, 1993 Se DISC
CARBOPLATIN
INJECTABLE; INJECTION
CARBOPLATIN
>D> AP PHARMACHEMIE 50MG/VIAL N76162 001 Oct 14, 2004 Se CRLD
>A> AP + 50MG/VIAL N76162 001 Oct 14, 2004 Se CRLD
>D> AP 150MG/VIAL N76162 002 Oct 14, 2004 Se CRLD
>A> AP + 150MG/VIAL N76162 002 Oct 14, 2004 Se CRLD
>D> AP 450MG/VIAL N76162 003 Oct 14, 2004 Se CRLD
>A> AP + 450MG/VIAL N76162 003 Oct 14, 2004 Se CRLD
>D> PARAPLATIN
>D> AP + BRISTOL MYERS 50MG/VIAL N19880 001 Mar 03, 1989 Se DISC
>A> @ 50MG/VIAL N19880 001 Mar 03, 1989 Se DISC
>D> AP + 150MG/VIAL N19880 002 Mar 03, 1989 Se DISC
>A> @ 150MG/VIAL N19880 002 Mar 03, 1989 Se DISC
>D> AP + 450MG/VIAL N19880 003 Mar 03, 1989 Se DISC
>A> @ 450MG/VIAL N19880 003 Mar 03, 1989 Se DISC
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>D> AP PHARMACHEMIE EQ 50MG/5ML (10MG/ML) N77269 001 Oct 14, 2004 Se CRLD
>A> AP + EQ 50MG/5ML (10MG/ML) N77269 001 Oct 14, 2004 Se CRLD
>D> AP EQ 150MG/15ML (10MG/ML) N77269 002 Oct 14, 2004 Se CRLD
>A> AP + EQ 150MG/15ML (10MG/ML) N77269 002 Oct 14, 2004 Se CRLD
>D> AP EQ 450MG/45ML (10MG/ML) N77269 003 Oct 14, 2004 Se CRLD
>A> AP + EQ 450MG/45ML (10MG/ML) N77269 003 Oct 14, 2004 Se CRLD
>D> AP TEVA PARENTERAL EQ 50MG/5ML (10MG/ML) N77139 001 Sep 21, 2005 Se CRLD
>A> AP + EQ 50MG/5ML (10MG/ML) N77139 001 Sep 21, 2005 Se CRLD
>D> AP EQ 150MG/15ML (10MG/ML) N77139 002 Sep 21, 2005 Se CRLD
>A> AP + EQ 150MG/15ML (10MG/ML) N77139 002 Sep 21, 2005 Se CRLD
>D> AP EQ 450MG/45ML (10MG/ML) N77139 003 Sep 21, 2005 Se CRLD
>A> AP + EQ 450MG/45ML (10MG/ML) N77139 003 Sep 21, 2005 Se CRLD
>D> AP EQ 600MG/60ML (10MG/ML) N77139 004 Sep 21, 2005 Se CRLD
>A> AP + EQ 600MG/60ML (10MG/ML) N77139 004 Sep 21, 2005 Se CRLD
CARISOPRODOL
>A> TABLET; ORAL
>A> SOMA
>A> MEDPOINTE PHARM 250MG N11792 004 Sep 13, 2007 Se NEWA
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
CAPSULE, EXTENDED RELEASE; ORAL
>A> TUSSICAPS
>A> TYCO HLTHCARE EQ 4MG MALEATE;EQ 5MG N77273 002 Sep 24, 2007 Se NEWA
>A> + EQ 8MG MALEATE;EQ 10MG N77273 001 Sep 24, 2007 Se NEWA
CICLOPIROX
SOLUTION; TOPICAL
>A> CICLOPIROX
>A> AT ACTAVIS MID 8% N78046 001 Sep 18, 2007 Se NEWA
>A> AT APOTEX CORP 8% N78172 001 Sep 18, 2007 Se NEWA
>A> AT G AND W LABS 8% N78233 001 Sep 18, 2007 Se NEWA
>A> AT HI TECH PHARMA 8% N78270 001 Sep 18, 2007 Se NEWA
>A> AT PERRIGO NEW YORK 8% N77623 001 Sep 18, 2007 Se NEWA
>A> AT SYNERX PHARMA 8% N78567 001 Sep 18, 2007 Se NEWA
>A> AT TARO PHARM INDS 8% N78144 001 Sep 18, 2007 Se NEWA
>A> AT TEVA PHARMS 8% N78079 001 Sep 18, 2007 Se NEWA
>A> AT TOLMAR 8% N77687 001 Sep 18, 2007 Se NEWA
>A> AT WATSON LABS 8% N78124 001 Sep 18, 2007 Se NEWA
PENLAC
>D> + SANOFI AVENTIS US 8% N21022 001 Dec 17, 1999 Se CFTG
>A> AT + 8% N21022 001 Dec 17, 1999 Se CFTG
CLOPIDOGREL BISULFATE
TABLET; ORAL
PLAVIX
>A> SANOFI AVENTIS US EQ 300MG BASE N20839 002 Sep 20, 2007 Se NEWA
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE
SYRUP; ORAL
PHENERGAN VC W/ CODEINE
>A> @ ANI PHARMS 10MG/5ML;5MG/5ML;6.25MG/5ML N08306 005 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 10MG/5ML;5MG/5ML;6.25MG/5ML N08306 005 Apr 02, 1984 Se CAHN
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN W/ CODEINE
>A> @ ANI PHARMS 10MG/5ML;6.25MG/5ML N08306 004 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 10MG/5ML;6.25MG/5ML N08306 004 Apr 02, 1984 Se CAHN
CYANOCOBALAMIN
SPRAY, METERED; NASAL
CALOMIST
>D> @ FLEMING 25UGM/SPRAY N22102 001 Jul 27, 2007 Se CMFD
>A> + 25UGM/SPRAY N22102 001 Jul 27, 2007 Se CMFD
DEXRAZOXANE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> TOTECT
>A> @ TOPOTARGET EQ 500MG BASE/VIAL N22025 001 Sep 06, 2007 Se DISC
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN W/ DEXTROMETHORPHAN
>A> @ ANI PHARMS 15MG/5ML;6.25MG/5ML N11265 002 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 15MG/5ML;6.25MG/5ML N11265 002 Apr 02, 1984 Se CAHN
ESTRADIOL VALERATE
INJECTABLE; INJECTION
DELESTROGEN
>D> + KING PHARMS 10MG/ML N09402 002 Se CTEC
>A> AO + 10MG/ML N09402 002 Se CTEC
ESTRADIOL VALERATE
>A> AO SANDOZ 10MG/ML N40628 001 Oct 04, 2007 Se NEWA
>A> AO 20MG/ML N40628 002 Oct 04, 2007 Se NEWA
>A> AO 40MG/ML N40628 003 Oct 04, 2007 Se NEWA
FERUMOXIDES
INJECTABLE; INJECTION
FERIDEX I.V.
>D> + ADV MAGNETICS EQ 11.2MG IRON/ML N20416 001 Aug 30, 1996 Se CAHN
>A> + AMAG PHARMS INC EQ 11.2MG IRON/ML N20416 001 Aug 30, 1996 Se CAHN
FERUMOXSIL
SUSPENSION; ORAL
GASTROMARK
>D> + ADV MAGNETICS EQ 0.175MG IRON/ML N20410 001 Dec 06, 1996 Se CAHN
>A> + AMAG PHARMS INC EQ 0.175MG IRON/ML N20410 001 Dec 06, 1996 Se CAHN
FLOXURIDINE
INJECTABLE; INJECTION
FLOXURIDINE
>D> AP BEDFORD 500MG/VIAL N75387 001 Apr 16, 2000 Se CRLD
>A> AP + 500MG/VIAL N75387 001 Apr 16, 2000 Se CRLD
>D> FUDR
>D> AP + HOSPIRA 500MG/VIAL N16929 001 Se DISC
>A> @ 500MG/VIAL N16929 001 Se DISC
FLUDARABINE PHOSPHATE
INJECTABLE; INJECTION
FLUDARABINE PHOSPHATE
>A> AP + EBEWE PHARMA 50MG/2ML(25MG/ML) N22137 001 Sep 21, 2007 Se NEWA
>D> + TEVA PARENTERAL 50MG/2ML (25MG/ML) N76661 001 Apr 28, 2004 Se CTEC
>A> AP + 50MG/2ML (25MG/ML) N76661 001 Apr 28, 2004 Se CTEC
FLUDEOXYGLUCOSE F-18
INJECTABLE; INTRAVENOUS
FLUDEOXYGLUCOSE F18
>A> + FEINSTEIN 20-200mCi/ML N21870 001 Aug 19, 2005 Se CAHN
>D> + NORTH SHORE LIJ 20-200mCi/ML N21870 001 Aug 19, 2005 Se CAHN
GABAPENTIN
CAPSULE; ORAL
GABAPENTIN
>A> AB HIKMA 100MG N78150 001 Sep 25, 2007 Se NEWA
>A> AB 300MG N78150 002 Sep 25, 2007 Se NEWA
>A> AB 400MG N78150 003 Sep 25, 2007 Se NEWA
GADODIAMIDE
INJECTABLE; INJECTION
ONMISCAN
>A> + GE HEALTHCARE 14.35GM/50ML(287MG/ML) N22066 001 Sep 05, 2007 Se NEWA
>A> + 28.7GM/100ML(287MG/ML) N22066 002 Sep 05, 2007 Se NEWA
HYDROCHLOROTHIAZIDE
CAPSULE; ORAL
HYDROCHLOROTHIAZIDE
>A> AB AUROBINDO 12.5MG N78164 001 Sep 18, 2007 Se NEWA
TABLET; ORAL
HYDROCHLOROTHIAZIDE
>A> AB APOTEX 25MG N40774 001 Oct 03, 2007 Se NEWA
>A> AB 50MG N40774 002 Oct 03, 2007 Se NEWA
>A> AB LANNETT 25MG N84325 001 Se CMFD
>A> AB 50MG N84324 001 Se CMFD
>D> @ PHARMERAL 25MG N84325 001 Se CMFD
>D> @ 50MG N84324 001 Se CMFD
HYDROCORTISONE BUTYRATE
CREAM; TOPICAL
LOCOID
>D> AB + FERNDALE LABS 0.1% N18514 001 Mar 31, 1982 Se CAHN
>A> AB + TRIAX PHARMS 0.1% N18514 001 Mar 31, 1982 Se CAHN
LOCOID LIPOCREAM
>D> + FERNDALE LABS 0.1% N20769 001 Sep 08, 1997 Se CAHN
>A> + TRIAX PHARMS 0.1% N20769 001 Sep 08, 1997 Se CAHN
LOTION; TOPICAL
LOCOID
>D> + FERNDALE LABS 0.1% N22076 001 May 18, 2007 Se CAHN
>A> + TRIAX PHARMS 0.1% N22076 001 May 18, 2007 Se CAHN
OINTMENT; TOPICAL
LOCOID
>D> AB + FERNDALE LABS 0.1% N18652 001 Oct 29, 1982 Se CAHN
>A> AB + TRIAX PHARMS 0.1% N18652 001 Oct 29, 1982 Se CAHN
SOLUTION; TOPICAL
LOCOID
>D> AT + FERNDALE LABS 0.1% N19116 001 Feb 25, 1987 Se CAHN
>A> AT + TRIAX PHARMS 0.1% N19116 001 Feb 25, 1987 Se CAHN
HYDROMORPHONE HYDROCHLORIDE
TABLET; ORAL
HYDROMORPHONE HYDROCHLORIDE
>D> KV PHARM 2MG N77311 001 Nov 09, 2005 Se CTEC
>A> AB 2MG N77311 001 Nov 09, 2005 Se CTEC
>D> 4MG N77311 002 Nov 09, 2005 Se CTEC
>A> AB 4MG N77311 002 Nov 09, 2005 Se CTEC
>A> AB TYCO HLTHCARE 2MG N78273 001 Sep 19, 2007 Se NEWA
>A> AB 4MG N78273 002 Sep 19, 2007 Se NEWA
HYDROXYCHLOROQUINE SULFATE
TABLET; ORAL
HYDROXYCHLOROQUINE SULFATE
>A> AB ZYDUS PHARMS 200MG N40657 001 Sep 21, 2007 Se NEWA
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
INJECTABLE; INJECTION
>A> HUMALOG MIX 50/50 KWIKPEN
>A> + LILLY 50 UNITS/ML;50 UNITS/ML N21018 002 Sep 06, 2007 Se NEWA
>A> HUMALOG MIX 75/25 KWIKPEN
>A> + LILLY 75 UNITS/ML;25 UNITS/ML N21017 002 Sep 06, 2007 Se NEWA
INSULIN LISPRO RECOMBINANT
INJECTABLE; INJECTION
>A> HUMALOG KWIKPEN
>A> + LILLY 100 UNITS/ML N20563 003 Sep 06, 2007 Se NEWA
LANTHANUM CARBONATE
TABLET, CHEWABLE; ORAL
FOSRENOL
>D> SHIRE EQ 250MG BASE N21468 001 Oct 26, 2004 Se DISC
>A> @ EQ 250MG BASE N21468 001 Oct 26, 2004 Se DISC
LEUCOVORIN CALCIUM
INJECTABLE; INJECTION
LEUCOVORIN CALCIUM
>D> AP BEDFORD EQ 50MG BASE/VIAL N89384 001 Sep 14, 1987 Se CRLD
>A> AP + EQ 50MG BASE/VIAL N89384 001 Sep 14, 1987 Se CRLD
>D> AP EQ 100MG BASE/VIAL N89717 001 Mar 28, 1988 Se CRLD
>A> AP + EQ 100MG BASE/VIAL N89717 001 Mar 28, 1988 Se CRLD
LEVOTHYROXINE SODIUM
>D> CAPSULE; ORAL
>D> TIROSINT
>D> INST BIOCHIMIQUE 0.013MG N22121 001 Aug 01, 2007 Se DISC
>A> @ 0.013MG N22121 001 Aug 01, 2007 Se DISC
>D> 0.025MG N21924 002 Oct 13, 2006 Se DISC
>A> @ 0.025MG N21924 002 Oct 13, 2006 Se DISC
>D> 0.05MG N21924 003 Oct 13, 2006 Se DISC
>A> @ 0.05MG N21924 003 Oct 13, 2006 Se DISC
>D> 0.075MG N21924 004 Oct 13, 2006 Se DISC
>A> @ 0.075MG N21924 004 Oct 13, 2006 Se DISC
>D> 0.1MG N21924 005 Oct 13, 2006 Se DISC
>A> @ 0.1MG N21924 005 Oct 13, 2006 Se DISC
>D> 0.125MG N21924 006 Oct 13, 2006 Se DISC
>A> @ 0.125MG N21924 006 Oct 13, 2006 Se DISC
>D> + 0.15MG N21924 007 Oct 13, 2006 Se DISC
>A> @ 0.15MG N21924 007 Oct 13, 2006 Se DISC
TABLET; ORAL
>D> LEVOLET
>D> BX VINTAGE 0.025MG N21137 001 Jun 06, 2003 Se DISC
>A> @ 0.025MG N21137 001 Jun 06, 2003 Se DISC
>D> BX 0.05MG N21137 002 Jun 06, 2003 Se DISC
>A> @ 0.05MG N21137 002 Jun 06, 2003 Se DISC
>D> BX 0.075MG N21137 003 Jun 06, 2003 Se DISC
>A> @ 0.075MG N21137 003 Jun 06, 2003 Se DISC
>D> BX 0.088MG N21137 004 Jun 06, 2003 Se DISC
>A> @ 0.088MG N21137 004 Jun 06, 2003 Se DISC
>D> BX 0.1MG N21137 005 Jun 06, 2003 Se DISC
>A> @ 0.1MG N21137 005 Jun 06, 2003 Se DISC
>D> BX 0.112MG N21137 006 Jun 06, 2003 Se DISC
>A> @ 0.112MG N21137 006 Jun 06, 2003 Se DISC
>D> BX 0.125MG N21137 007 Jun 06, 2003 Se DISC
>A> @ 0.125MG N21137 007 Jun 06, 2003 Se DISC
>D> BX 0.137MG N21137 008 Jun 06, 2003 Se DISC
>A> @ 0.137MG N21137 008 Jun 06, 2003 Se DISC
>D> BX 0.15MG N21137 009 Jun 06, 2003 Se DISC
>A> @ 0.15MG N21137 009 Jun 06, 2003 Se DISC
>D> BX 0.175MG N21137 010 Jun 06, 2003 Se DISC
>A> @ 0.175MG N21137 010 Jun 06, 2003 Se DISC
>D> BX 0.2MG N21137 011 Jun 06, 2003 Se DISC
>A> @ 0.2MG N21137 011 Jun 06, 2003 Se DISC
>D> BX 0.3MG N21137 012 Jun 06, 2003 Se DISC
>A> @ 0.3MG N21137 012 Jun 06, 2003 Se DISC
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC;
INJECTABLE; INJECTION
ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
>D> B BRAUN 30MG/100ML;37MG/100ML;0.82MG/10 N19696 001 Sep 29, 1989 Se CRLD
>A> + 30MG/100ML;37MG/100ML;0.82MG/10 N19696 001 Sep 29, 1989 Se CRLD
METHIMAZOLE
TABLET; ORAL
METHIMAZOLE
>A> AB CARACO 5MG N40870 001 Sep 25, 2007 Se NEWA
>A> AB 10MG N40870 002 Sep 25, 2007 Se NEWA
METOPROLOL TARTRATE
INJECTABLE; INJECTION
METOPROLOL TARTRATE
>A> AP SANDOZ 1MG/ML N77360 001 Oct 02, 2007 Se NEWA
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL
MINOCIN
>D> AB + TRIAX PHARMS EQ 100MG BASE N50649 002 May 31, 1990 Se CRLD
>A> AB EQ 100MG BASE N50649 002 May 31, 1990 Se CRLD
MINOCYCLINE HYDROCHLORIDE
>D> AB TEVA EQ 100MG BASE N63009 001 Mar 02, 1992 Se CRLD
>A> AB + EQ 100MG BASE N63009 001 Mar 02, 1992 Se CRLD
>D> MORICIZINE HYDROCHLORIDE
>D> TABLET; ORAL
>D> ETHMOZINE
>D> SHIRE 200MG N19753 001 Jun 19, 1990 Se DISC
>A> @ 200MG N19753 001 Jun 19, 1990 Se DISC
>D> 250MG N19753 002 Jun 19, 1990 Se DISC
>A> @ 250MG N19753 002 Jun 19, 1990 Se DISC
>D> + 300MG N19753 003 Jun 19, 1990 Se DISC
>A> @ 300MG N19753 003 Jun 19, 1990 Se DISC
MORPHINE SULFATE
INJECTABLE; INJECTION
MORPHINE SULFATE
>D> AP MALLINCKRODT 1MG/ML N20631 001 Jul 03, 1996 Se DISC
>A> @ 1MG/ML N20631 001 Jul 03, 1996 Se DISC
>D> + 2MG/ML N20631 002 Jul 03, 1996 Se DISC
>A> @ 2MG/ML N20631 002 Jul 03, 1996 Se DISC
TABLET, EXTENDED RELEASE; ORAL
MORPHINE SULFATE
>A> AB KV PHARM 100MG N77855 001 Sep 27, 2007 Se NEWA
>A> AB 200MG N77855 002 Sep 27, 2007 Se NEWA
NIFEDIPINE
TABLET, EXTENDED RELEASE; ORAL
NIFEDIPINE
>A> AB2 OSMOTICA PHARM 90MG N77410 001 Oct 03, 2007 Se NEWA
OFLOXACIN
SOLUTION/DROPS; OTIC
FLOXIN OTIC
>D> + DAIICHI 0.3% N20799 001 Dec 16, 1997 Se CFTG
>A> AT + 0.3% N20799 001 Dec 16, 1997 Se CFTG
>A> OFLOXACIN
>A> AT APOTEX INC 0.3% N76527 001 Sep 28, 2007 Se NEWA
OXCARBAZEPINE
TABLET; ORAL
>A> OXCARBAZEPINE
>A> AB GLENMARK 150MG N77802 001 Oct 09, 2007 Se NEWA
>A> AB 300MG N77802 002 Oct 09, 2007 Se NEWA
>A> AB 600MG N77802 003 Oct 09, 2007 Se NEWA
>A> AB ROXANE 150MG N77795 001 Oct 09, 2007 Se NEWA
>A> AB 300MG N77795 002 Oct 09, 2007 Se NEWA
>A> AB 600MG N77795 003 Oct 09, 2007 Se NEWA
TRILEPTAL
>D> NOVARTIS 150MG N21014 001 Jan 14, 2000 Se CFTG
>A> AB 150MG N21014 001 Jan 14, 2000 Se CFTG
>D> 300MG N21014 002 Jan 14, 2000 Se CFTG
>A> AB 300MG N21014 002 Jan 14, 2000 Se CFTG
>D> + 600MG N21014 003 Jan 14, 2000 Se CFTG
>A> AB + 600MG N21014 003 Jan 14, 2000 Se CFTG
PEMETREXED DISODIUM
INJECTABLE; IV (INFUSION)
ALIMTA
>A> + LILLY EQ 100MG BASE/VIAL N21462 002 Sep 07, 2007 Se NEWA
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN VC
>A> @ ANI PHARMS 5MG/5ML;6.25MG/5ML N08604 003 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 5MG/5ML;6.25MG/5ML N08604 003 Apr 02, 1984 Se CAHN
PRAMLINTIDE ACETATE
INJECTABLE; SUBCUTANEOUS
SYMLIN
>A> AMYLIN EQ 1.5MG BASE/1.5ML (EQ 1MG N21332 002 Sep 25, 2007 Se NEWA
>A> EQ 2.7MG BASE/2.7ML (EQ 1MG N21332 003 Sep 25, 2007 Se NEWA
>D> + EQ 3MG BASE/5ML (EQ 0.6MG N21332 001 Mar 16, 2005 Se CPOT
>A> + EQ 3MG BASE/5ML (EQ 600UGM N21332 001 Mar 16, 2005 Se CPOT
PREDNISOLONE
SYRUP; ORAL
PREDNISOLONE
>A> AA VINTAGE 15MG/5ML N40775 001 Sep 21, 2007 Se NEWA
PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN FORTIS
>A> @ ANI PHARMS 25MG/5ML N08381 003 Se CAHN
>D> @ WYETH AYERST 25MG/5ML N08381 003 Se CAHN
PHENERGAN PLAIN
>A> @ ANI PHARMS 6.25MG/5ML N08381 004 Apr 18, 1984 Se CAHN
>D> @ WYETH AYERST 6.25MG/5ML N08381 004 Apr 18, 1984 Se CAHN
QUININE SULFATE
CAPSULE; ORAL
>A> QUALAQUIN
>A> + AR HOLDING CO 324MG N21799 001 Aug 12, 2005 Se CTNA
>D> QUININE SULFATE
>D> + AR HOLDING CO 324MG N21799 001 Aug 12, 2005 Se CTNA
RANITIDINE HYDROCHLORIDE
SYRUP; ORAL
RANITIDINE HYDROCHLORIDE
>A> AA APOTEX EQ 15MG BASE/ML N77602 001 Sep 17, 2007 Se NEWA
>A> AA PHARM ASSOC EQ 15MG BASE/ML N77405 001 Sep 21, 2007 Se NEWA
RISEDRONATE SODIUM
TABLET; ORAL
ACTONEL
>D> PROCTER AND 5MG N20835 002 Apr 14, 2000 Se CFTG
>A> AB 5MG N20835 002 Apr 14, 2000 Se CFTG
>D> 30MG N20835 001 Mar 27, 1998 Se CFTG
>A> AB 30MG N20835 001 Mar 27, 1998 Se CFTG
>D> + 35MG N20835 003 May 25, 2002 Se CFTG
>A> AB + 35MG N20835 003 May 25, 2002 Se CFTG
>A> RISEDRONATE SODIUM
>A> AB TEVA PHARMS 5MG N77132 001 Oct 05, 2007 Se NEWA
>A> AB 30MG N77132 002 Oct 05, 2007 Se NEWA
>A> AB 35MG N77132 003 Oct 05, 2007 Se NEWA
SELEGILINE
FILM, EXTENDED RELEASE; TRANSDERMAL
EMSAM
>D> SOMERSET 6MG/24HR N21336 001 Feb 27, 2006 Se CRLD
>A> + 6MG/24HR N21336 001 Feb 27, 2006 Se CRLD
>D> + 12MG/24HR N21336 003 Feb 27, 2006 Se CRLD
>A> 12MG/24HR N21336 003 Feb 27, 2006 Se CRLD
SODIUM POLYSTYRENE SULFONATE
SUSPENSION; ORAL, RECTAL
>A> KIONEX
>A> AA PADDOCK 15GM/60ML N40028 001 Sep 17, 2007 Se NEWA
TERBINAFINE HYDROCHLORIDE
>A> GRANULE; ORAL
>A> LAMISIL
>A> NOVARTIS EQ 125MG BASE/PACKET N22071 001 Sep 28, 2007 Se NEWA
>A> + EQ 187.5MG BASE/PACKET N22071 002 Sep 28, 2007 Se NEWA
None for this month.
Back
to Top
Back to Additions/Deletions Index
Date created: October 10, 2007 |
![](https://webarchive.library.unt.edu/eot2008/20090118123536im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |